ONCASPAR is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Servier Pharmaceuticals Llc. The primary component is Pegaspargase.
Product ID | 72694-954_030c8653-7dba-49ee-94d7-e94175d3efdf |
NDC | 72694-954 |
Product Type | Human Prescription Drug |
Proprietary Name | ONCASPAR |
Generic Name | Pegaspargase |
Dosage Form | Injection, Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2020-01-02 |
Marketing Category | BLA / BLA |
Application Number | BLA103411 |
Labeler Name | Servier Pharmaceuticals LLC |
Substance Name | PEGASPARGASE |
Active Ingredient Strength | 750 [iU]/mL |
Pharm Classes | Asparaginase [CS],Asparagine-specific Enzyme [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-01-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103411 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2020-01-02 |
Ingredient | Strength |
---|---|
PEGASPARGASE | 750 [iU]/mL |
NDC | Brand Name | Generic Name |
---|---|---|
0944-3810 | ONCASPAR | Pegaspargase |
72694-954 | ONCASPAR | Pegaspargase |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ONCASPAR 79384548 not registered Live/Pending |
SERVIER IP UK LIMITED 2023-10-16 |
ONCASPAR 74278090 1809883 Live/Registered |
SERVIER IP UK LIMITED 1992-05-26 |